Pharma company funding nonprofit’s over-the-counter naloxone
Purdue Pharma, the embattled maker of OxyContin, announced a $3.42 million grant to support a nonprofit pharmaceutical company's development
Purdue Pharma, the embattled maker of OxyContin, announced a $3.42 million grant to support a nonprofit pharmaceutical company's development